{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-014323","form_type":"8-K","ticker":null,"cik":"0000764195","company_name":"VBI Vaccines Inc/BC","filed_at":"2024-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.928169+00:00","generated_at":"2026-06-04T00:13:39.452078+00:00","sec_items":["1.01","2.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"VBI Vaccines raises $2M in registered direct offering; discloses $23.7M cash as of Dec 31, 2023","bullets":["Sold 2,272,728 common shares at $0.88 each with warrants to buy same at $0.76, 5-year term.","Net proceeds ~$1.7M after placement agent fees; funds for working capital and general corporate purposes.","Preliminary unaudited cash balance as of Dec 31, 2023: approximately $23.7M.","Offering closed April 11, 2024; H.C. Wainwright acted as exclusive placement agent.","Placement agent received warrants for 136,364 shares at $1.10 per share."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-014323","json":"https://secwatch.observer/filing/0001493152-24-014323.json","markdown":"https://secwatch.observer/filing/0001493152-24-014323.md","text":"https://secwatch.observer/filing/0001493152-24-014323.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/764195/000149315224014323/0001493152-24-014323-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/764195/000149315224014323/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T00:13:39.452078+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8bd195a384107b417e2b21420593c8454755a8c2","claim":"VBI Vaccines Inc/BC entered into Securities Purchase Agreement with institutional investors valued at $0.88 per Share (effective 2024-04-09).","evidence_excerpt":"VBI Vaccines Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with institutional investors, pursuant to which the Company agreed to sell and issue, in a registered direct offering (the “Offering”), (i) 2,272,728 common shares (the “Shares”) of the Company, no par value per share (the “Common Shares”), and (ii) warrants (the “Common Warrants”) to purchase up to 2,272,728 Common Shares, at a purchase price of $0.88 per Share and associated Common Warrant.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/764195/000149315224014323/0001493152-24-014323-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"institutional investors"},{"label":"Value","value":"$0.88 per Share"},{"label":"Effective","value":"2024-04-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}